December 7, 2017
Wilmington, MA – Rigaku Corporation is pleased to announce that Rigaku Analytical Devices, a leading provider of innovative handheld Raman spectrometers, has announced a library update in its Progeny ResQ software giving users the ability to identify more opioids, including various fentanyl compounds. Designed with customer needs in mind, the Progeny™ ResQ 1064nm handheld Raman analyzer provides the industry’s most comprehensive [...]
Shimadzu Scientific Instruments and Restek Corporation Announce Distribution Agreement
December 7, 2017
COLUMBIA, MD — Shimadzu Scientific Instruments (SSI) and Restek Corporation have entered a partnership that enables the sales of Restek consumables by SSI. Under the terms of this agreement, SSI will promote and sell Restek consumables throughout its geographic territory, which includes the United States, Latin America, and the Caribbean. Through this partnership, SSI will [...]
STEMBIOSYS ANNOUNCES NEW EUROPEAN DISTRIBUTOR FOR STEM CELL RESEARCH PRODUCTS
December 7, 2017
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with Caltag Medsystems Ltd. to distribute and market StemBioSys products. Caltag will distribute StemBioSys products in the European Union. Initially, the agreement will cover StemBioSys’ cell expansion products, but as additional products are added to StemBioSys’ portfolio in the future, these [...]
December 7, 2017
The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions CARLSBAD, Calif. -- The Centers for Medicare & Medicaid Services (CMS) has proposed coverage for the Oncomine Dx Target Test as part of a national coverage determination (NCD) for next-generation sequencing (NGS) in vitro diagnostic (IVD) tests. Once [...]
December 7, 2017
Zurich / Glattbrugg | Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, announce their partnership. Thanks to this partnership, JPK’s NanoWizard® AFM users will now be [...]
BGI & Sanguine Join Forces to Increase Speed and Efficiency of Precision Clinical Trial Recruitment
December 7, 2017
SHENZHEN, China, CAMBRIDGE, Mass. and SHERMAN OAKS, Calif. — BGI Genomics, a global leader in Next Generation Sequencing Services, and Sanguine BioSciences, Inc., a builder of data-integrated patient communities, have joined forces to develop a database of combined genomic and clinical data to increase the speed and efficiency of Precision Clinical Trial Recruitment. For their [...]
The 1000th Esco Miri Customer finds convenience with SAFE Sens integration
December 7, 2017
When SAFE Sens integration to the Esco Miri® benchtop incubator was announced at ESHRE last year, it was well received by IVF laboratories worldwide. The ability to measure, record and archive pH during a cycle, provides the lab extra assurance of a stable incubator environment throughout the five (5) to seven (7) days of in vitro embryo [...]
December 6, 2017
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), is pleased to announce that it has achieved ISO 9001:2015 certification for the design, development, training, servicing and support of Laboratory Information Management Systems. ATL first obtained ISO certification in 2001 and continues to be one of the few independent LIMS vendors [...]
SYGNIS AG Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market
December 6, 2017
- TruePrime™ cfDNA kit offers superior selectivity and preferential amplification - Liquid biopsy market is a fast-growing multibillion market - TruePrime™ cfDNA is fully scalable from small to mid-scale programs Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, [...]
BGI AND HUMMINGBIRD DIAGNOSTICS SIGN MEMORANDUM OF UNDERSTANDING
December 6, 2017
SHENZHEN, HEIDELBERG – BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbird Diagnostics GmbH, Heidelberg, Germany, an innovator in miRNA-based diagnostic tests from blood for early disease detection, today announced that they have signed a Memorandum of Understanding (MoU) intending to establish a broad collaboration in miRNA-based [...]
